Detection of risk signals for ustekinumab in the real world using the FDA Adverse Event Reporting System (FAERS)
Our study identified the risk signals for ustekinumab using real-world data and provides further evidence to support its rational use. Due to the limitations of FAERS, further studies are warranted to verify these findings.
Authors
- Kanghuai Zhang
- Yi Zhao (ORCID: https://orcid.org/0000-0003-2555-2154)
- Na Wang (ORCID: https://orcid.org/0000-0001-6050-3150)
- Zelin Li (ORCID: https://orcid.org/0000-0001-9633-300X)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1080/14740338.2024.2446409
- Citations
- 2
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.88